Jensen Huang, NVIDIA Conveying Vision to Employees The company vision is conveyed through telling a story. Even though Jensen doesn’t enjoy public speaking or think of himself as an orator, he understands the importance of speaking to
Jensen Huang, NVIDIA Technologies of the Future Jensen describes 3D technology that he expects will become popular in the near future: lightweight displays that can be worn as goggles allow the user to be immersed in a
Jensen Huang, NVIDIA NVIDIA’s Prospects and the Future of the Industry Business at NVIDIA is going well — they are selling new products and entering new markets. Though Chinese and Indian companies are threatening their American counterparts, Jensen is enthusiastic about
Jensen Huang, NVIDIA Positioning NVIDIA as More Than a PC-Based Company Will NVIDIA have to re-position itself with the slowing of the PC industry? Though NVIDIA is traditionally a PC-based company, in reality the PC-market share is only 40%. However, it
Thomas Fogarty, Fogarty Engineering In conversation with: David Cassak Envisioning the First Balloon Catheter [Introduction by David Cassak] Tom Fogarty explains that he became interested in medicine “by accident.” He discusses his early design development and how he turned a clinical problem into a
Paul Yock, Stanford University The Accidental Entrepreneur Paul Yock, Co-Chair of Stanford’s Department of Bioengineering and Director of the Stanford Program in Biodesign, describes himself as an accidental tourist in entrepreneurship. He talks about his love for
Paul Yock, Stanford University Biotech Bay: The Other Silicon Valley Yock talks about the Biotech bay – the other Silicon Valley, and how the products offered are based on the science of genetics. Medtech focuses on instruments, equipments, and is
Paul Yock, Stanford University Cardiovascular Disease vs. Bioterrorism Yock focuses on cardio vascular disease, which is a very profound disease – it is the # 1 killer in the western world. About half of all Medtech companies have
Paul Yock, Stanford University Beginning of Less Invasive Cardiac Techniques: Charles Dotter Yock tells the story of how less invasive cardiac techniques got started. He shares a video clip from Charles Dotter, better known as crazy Charlie
Paul Yock, Stanford University History of Balloon Angioplasty Catheter: Thomas Fogarty Yock continues the story about a non-invasive cardiac technique and how it quickly had a Stanford connection. Thomas Fogarty, a surgeon at Stanford, worked with Charles Dotter and soon developed
Paul Yock, Stanford University Coronary Angioplasty: Andreas Geruntzig Yock talks about the fundamental problem of applying the balloon technology to dilating the heart narrowing. The balloon was too compliant. He talks about the development of a balloon that
Paul Yock, Stanford University Guidewire Catheter: John Simpson John Simpson, a Stanford trainee in cardiology, thought the catheter system didn’t work so he worked in his kitchen in Menlo Park to develop a catheter that is easier to
Paul Yock, Stanford University Mentoring Changed My Life When Yock started getting involved in training, he worked with John Simpson and the mentoring changed his life. One thing that was starting to become clear in mid 80’s was
Paul Yock, Stanford University Testing Medical Devices and Overcoming FDA Hurdles Yock talks about his company and his experience with the FDA and a Norwegian government official who approved their technology very quickly.
Paul Yock, Stanford University Using Stents as Drug Delivery System Yock talks about further developments moving from radiations to using drugs with the stents as a carrying mechanism. This is a blockbuster idea which has dropped the recurrence rate from
Paul Yock, Stanford University Opportunity: How to Cover Economic Loss from Stent Use? Yock mentions a problem – there is a tremendous diseconomy because loss per stent has gone up. There will be serious economic trouble with this new technology, he says.
Paul Yock, Stanford University Medtech: What's Going on in Region and at Stanford Yock comments about what is going on in the region and at Stanford in the Medtech sector. Things that make up regional advantage in this sector are very similar with
Paul Yock, Stanford University Interdisciplinary Biomed Education and Clark Center at Stanford Yock talks about next generation of Medtech and biotech innovation at Stanford. The idea behind the Clark Center is to put something physically at the interface between school of engineering,
Paul Yock, Stanford University Identify the Need: Invention and Being Contrary Yock declares that the key is to identify needs correctly. He suggests that one finds an area of strong consensus among thought leaders–and then do something different.
Paul Yock, Stanford University MedTech: Keep it Simple Yock states that the most important thing he learned in his in whole career was that in medtech, you have to keep it simple. The reason is that people in
Paul Yock, Stanford University Patents Dominate MedTech Yock explains why MedTech is dominated by the importance of patents. People who don't patent their early ideas lose out.
Paul Yock, Stanford University FDA and Medicare Yock emphasizes that in MedTech, there are two forces that can make your life miserable– the FDA and Medicare. He emphasizes the importance of understanding how medicare will handle new
Paul Yock, Stanford University Think Big and Pay Close Attention to Market Assessment Yock suggests that entrepreneurs pick a big idea. He gives an example of the smart needle. Pay attention to market assessment; time is a valuable resource, he adds.
Paul Yock, Stanford University Envisioning the Future in Medtech: Go Where the Puck Will Be Yock's final suggestion comes from Wayne Gretzky. How is he so successful? Gretzky knows how to go where the puck will be, he says.